• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

月经周期对原发性乳腺癌活检组织中雌激素和孕激素受体浓度的影响。

Influence of the menstrual cycle on the concentrations of estrogen and progesterone receptors in primary breast cancer biopsies.

作者信息

Smyth C M, Benn D E, Reeve T S

机构信息

Department of Surgery, University of Sydney, Royal North Shore Hospital, St. Leonards N.S.W., Australia.

出版信息

Breast Cancer Res Treat. 1988 Apr;11(1):45-50. doi: 10.1007/BF01807557.

DOI:10.1007/BF01807557
PMID:3382762
Abstract

There is controversy in the literature regarding the effects of endogenous hormones on estrogen receptors (ER) and progesterone receptors (PR) in young women with breast cancer. We studied 117 young women with primary breast cancer and assessed their breast biopsies for ER and PR. The women had a record of their last menstrual period prior to breast biopsy. The menstrual cycle was divided into four phases--early proliferative (days 1-7), late proliferative (days 8-15), early secretory (days 16-22), and late secretory (days 23-30). There were lower levels of both ER and PR in biopsies excised during the early secretory phase than in other phases of the cycle; early proliferative phase receptor positive medians of ER = 77 fmol/mg protein and PR = 467 fmol/mg protein fell to ER = 28 fmol/mg and PR = 128 fmol/mg protein in the early secretory phase.

摘要

关于内源性激素对年轻乳腺癌女性雌激素受体(ER)和孕激素受体(PR)的影响,文献中存在争议。我们研究了117名原发性乳腺癌年轻女性,并对她们的乳腺活检组织进行了ER和PR评估。这些女性在乳腺活检前有末次月经记录。月经周期分为四个阶段——增殖早期(第1 - 7天)、增殖晚期(第8 - 15天)、分泌早期(第16 - 22天)和分泌晚期(第23 - 30天)。与月经周期的其他阶段相比,在分泌早期切除的活检组织中ER和PR水平均较低;增殖早期受体阳性中位数ER = 77 fmol/mg蛋白、PR = 467 fmol/mg蛋白,在分泌早期降至ER = 28 fmol/mg、PR = 128 fmol/mg蛋白。

相似文献

1
Influence of the menstrual cycle on the concentrations of estrogen and progesterone receptors in primary breast cancer biopsies.月经周期对原发性乳腺癌活检组织中雌激素和孕激素受体浓度的影响。
Breast Cancer Res Treat. 1988 Apr;11(1):45-50. doi: 10.1007/BF01807557.
2
Survival of premenopausal breast carcinoma patients in relation to menstrual cycle timing of surgery and estrogen receptor/progesterone receptor status of the primary tumor.绝经前乳腺癌患者的生存情况与手术时的月经周期时间及原发肿瘤的雌激素受体/孕激素受体状态的关系。
Cancer. 1999 Nov 15;86(10):2053-8. doi: 10.1002/(sici)1097-0142(19991115)86:10<2053::aid-cncr24>3.0.co;2-h.
3
Estrogen and progesterone receptors in the normal female breast.正常女性乳房中的雌激素和孕激素受体。
Cancer Res. 1991 Apr 1;51(7):1817-22.
4
Endometrial stromal sarcoma expression of estrogen receptors, progesterone receptors and estrogen-induced srp27 (24K) suggests hormone responsiveness.子宫内膜间质肉瘤中雌激素受体、孕激素受体及雌激素诱导的srp27(24K)的表达提示其对激素有反应性。
J Steroid Biochem Mol Biol. 1992 Mar;41(3-8):589-96. doi: 10.1016/0960-0760(92)90389-z.
5
Oestrogen and progesterone receptor status in bone biopsy specimens from patients with breast cancer.乳腺癌患者骨活检标本中的雌激素和孕激素受体状态。
Eur J Cancer. 1991;27(2):115-8. doi: 10.1016/0277-5379(91)90465-p.
6
Enzyme immunoassay of estrogen and progesterone receptors in drill biopsy specimens from breast cancer.
Eur J Cancer Clin Oncol. 1989 May;25(5):809-14. doi: 10.1016/0277-5379(89)90125-9.
7
Distribution, frequency, and quantitative analysis of estrogen, progesterone, androgen, and glucocorticoid receptors in human breast cancer.人乳腺癌中雌激素、孕激素、雄激素和糖皮质激素受体的分布、频率及定量分析。
Cancer Res. 1979 May;39(5):1447-54.
8
Quantitative association between HER-2/neu and steroid hormone receptors in hormone receptor-positive primary breast cancer.激素受体阳性原发性乳腺癌中HER-2/neu与类固醇激素受体之间的定量关联
J Natl Cancer Inst. 2003 Jan 15;95(2):142-53. doi: 10.1093/jnci/95.2.142.
9
Changing estrogen and progesterone receptor patterns in breast carcinoma during the menstrual cycle and menopause.月经周期及绝经期间乳腺癌中雌激素和孕激素受体模式的变化
Cancer. 1998 Aug 15;83(4):698-705.
10
Elastosis and steroid receptors in primary breast cancer.原发性乳腺癌中的弹性组织变性与类固醇受体
Braz J Med Biol Res. 1985;18(3):279-83.

引用本文的文献

1
QSTR Models in Dioxins and Dioxin-like Compounds Provide Insights into Gene Expression Dysregulation.二噁英及二噁英类化合物中的定量构效关系模型有助于深入了解基因表达失调。
Toxics. 2024 Aug 17;12(8):597. doi: 10.3390/toxics12080597.
2
Theoretical Studies on the Quantitative Structure-Toxicity Relationship of Polychlorinated Biphenyl Congeners Reveal High Affinity Binding to Multiple Human Nuclear Receptors.多氯联苯同系物定量结构-毒性关系的理论研究表明其与多种人类核受体具有高亲和力结合。
Toxics. 2024 Jan 8;12(1):49. doi: 10.3390/toxics12010049.
3
William L. McGuire Memorial Symposium. Estrogen and progestin effects in human breast carcinogenesis.

本文引用的文献

1
Evidence that estrogen-receptor-negative, progesterone-receptor-positive breast and ovarian carcinomas contain estrogen receptor.雌激素受体阴性、孕激素受体阳性的乳腺癌和卵巢癌含有雌激素受体的证据。
Cancer. 1981 Sep 1;48(5):1215-20. doi: 10.1002/1097-0142(19810901)48:5<1215::aid-cncr2820480527>3.0.co;2-3.
2
Estradiol receptor in human breast cancers throughout the menstrual cycle.整个月经周期中人类乳腺癌中的雌二醇受体。
Oncology. 1982;39(6):340-4. doi: 10.1159/000225667.
3
Two aids in oestrogen receptor characterisation.雌激素受体特征鉴定的两种辅助方法。
威廉·L·麦圭尔纪念研讨会。雌激素和孕激素在人类乳腺癌发生中的作用。
Breast Cancer Res Treat. 1993;27(1-2):3-15. doi: 10.1007/BF00683189.
4
Prognostic effect of timing of operation in relation to menstrual phase of breast cancer patient--fact or fallacy.乳腺癌患者手术时机与月经周期的预后影响——事实还是谬误
Br J Cancer. 1995 Jan;71(1):124-7. doi: 10.1038/bjc.1995.25.
5
Influence of tamoxifen-medroxyprogesterone sequential therapy on estrogen and progesterone receptor contents of breast cancer.他莫昔芬-甲羟孕酮序贯疗法对乳腺癌雌激素和孕激素受体含量的影响。
Jpn J Cancer Res. 1989 Mar;80(3):244-8. doi: 10.1111/j.1349-7006.1989.tb02300.x.
6
Different methylation of oestrogen receptor DNA in human breast carcinomas with and without oestrogen receptor.有雌激素受体和无雌激素受体的人乳腺癌中雌激素受体DNA的不同甲基化情况
Br J Cancer. 1990 Feb;61(2):270-5. doi: 10.1038/bjc.1990.50.
Aust N Z J Surg. 1982 Apr;52(2):161-4. doi: 10.1111/j.1445-2197.1982.tb06093.x.
4
Estrogen and progesterone receptor profile patterns in primary breast cancer.原发性乳腺癌中的雌激素和孕激素受体谱模式
Breast Cancer Res Treat. 1983;3(1):103-10. doi: 10.1007/BF01806241.
5
Relationship of age and menopausal status to estrogen receptor content in primary carcinoma of the breast.年龄和绝经状态与乳腺癌原发癌雌激素受体含量的关系。
Ann Surg. 1983 Feb;197(2):123-7. doi: 10.1097/00000658-198302000-00001.
6
Prognostic factors in primary breast cancer.原发性乳腺癌的预后因素。
Breast Cancer Res Treat. 1983;3 Suppl:S69-72. doi: 10.1007/BF01855130.
7
Correlations between estrogen receptor, progesterone receptor, and patient characteristics in human breast cancer.雌激素受体、孕激素受体与人乳腺癌患者特征之间的相关性
J Clin Oncol. 1984 Oct;2(10):1102-9. doi: 10.1200/JCO.1984.2.10.1102.
8
Variations in estrogen and progesterone receptor content in premenopausal breast cancer patients throughout the menstrual cycle.绝经前乳腺癌患者在整个月经周期中雌激素和孕激素受体含量的变化。
Tumori. 1984 Aug 31;70(4):339-44. doi: 10.1177/030089168407000408.
9
Relation of estrogen and/or progesterone receptor content of breast cancer to patient outcome following adjuvant chemotherapy.
Breast Cancer Res Treat. 1983;3(4):355-64. doi: 10.1007/BF01807588.
10
Steroid hormone receptors in breast cancer treatment strategy.乳腺癌治疗策略中的类固醇激素受体
Recent Prog Horm Res. 1980;36:135-56. doi: 10.1016/b978-0-12-571136-4.50010-3.